{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:03:41Z","timestamp":1795089821714,"version":"4.10.2"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.expneurol.2022.114108","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T23:08:02Z","timestamp":1652137682000},"page":"114108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Neurogenic inflammation as a novel treatment target for chronic pain syndromes"],"prefix":"10.1016","volume":"356","author":[{"given":"Matthias F.","family":"Seidel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"H\u00fcgle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barton","family":"Morlion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Koltzenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"MaassenVanDenBrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Zieglg\u00e4nsberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.expneurol.2022.114108_bb0005","doi-asserted-by":"crossref","first-page":"29069","DOI":"10.3390\/ijms161226151","article-title":"Mast cell-mediated mechanisms of nociception","volume":"16","author":"Aich","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2022.114108_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.549038","article-title":"Giving researchers a headache - sex and gender differences in migraine","volume":"11","author":"Al-Hassany","year":"2020","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.expneurol.2022.114108_bb0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2174\/1570159X11311060003","article-title":"Tissue injury and related mediators of pain exacerbation","volume":"11","author":"Amaya","year":"2013","journal-title":"Curr. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.expneurol.2022.114108_bb0020","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.40820","article-title":"Associations of symptomatic knee osteoarthritis with Histopathologic features in Subchondral bone","volume":"71","author":"Aso","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"9","key":"10.1016\/j.expneurol.2022.114108_bb0025","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.joca.2020.05.010","article-title":"Contribution of nerves within osteochondral channels to osteoarthritis knee pain in humans and rats","volume":"28","author":"Aso","year":"2020","journal-title":"Osteoarthr. Cartil."},{"issue":"7","key":"10.1016\/j.expneurol.2022.114108_bb0030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-019-0147-2","article-title":"Pain and immunity: implications for host defence","volume":"19","author":"Baral","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.expneurol.2022.114108_bb0035","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2147\/JPR.S247472","article-title":"Nerve growth factor signaling and its contribution to pain","volume":"13","author":"Barker","year":"2020","journal-title":"J. Pain Res."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.biopsycho.2011.12.015","article-title":"What\u2019s wrong with fear conditioning?","volume":"92","author":"Beckers","year":"2013","journal-title":"Biol. Psychol."},{"issue":"2","key":"10.1016\/j.expneurol.2022.114108_bb0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0950-3579(96)80016-1","article-title":"The immune effects of neuropeptides","volume":"10","author":"Berczi","year":"1996","journal-title":"Baillieres Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.expneurol.2022.114108_bb0050","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ana.22002","article-title":"How to design an opioid drug that causes reduced tolerance and dependence","volume":"67","author":"Berger","year":"2010","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.expneurol.2022.114108_bb0055","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.brat.2004.11.006","article-title":"How does persistent pain develop? An analysis of the relationship between psychological variables, pain and function across stages of chronicity","volume":"43","author":"Boersma","year":"2005","journal-title":"Behav. Res. Ther."},{"issue":"17\u201318","key":"10.1016\/j.expneurol.2022.114108_bb0060","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.drudis.2012.05.004","article-title":"Decision-making using fMRI in clinical drug development: revisiting NK-1 receptor antagonists for pain","volume":"17","author":"Borsook","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.expneurol.2022.114108_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/PROM.S62879","article-title":"Impact of tofacitinib on patient outcomes in rheumatoid arthritis - review of clinical studies","volume":"7","author":"Boyce","year":"2016","journal-title":"Patient Relat Outcome Meas"},{"issue":"4","key":"10.1016\/j.expneurol.2022.114108_bb2500","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2015","journal-title":"Eur. J. Pain."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ana.10785","article-title":"Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization","volume":"55","author":"Burstein","year":"2004","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.expneurol.2022.114108_bb0075","article-title":"IL-4, JAK-STAT signaling, and pain","volume":"2","author":"Busch-Dienstfertig","year":"2013","journal-title":"JAKSTAT"},{"issue":"7","key":"10.1016\/j.expneurol.2022.114108_bb0080","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrn3516","article-title":"Cognitive and emotional control of pain and its disruption in chronic pain","volume":"14","author":"Bushnell","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114108_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577406","article-title":"The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception","volume":"349","author":"Cappoli","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"16","key":"10.1016\/j.expneurol.2022.114108_bb0090","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1113\/jphysiol.2013.269654","article-title":"Nociceptive primary afferents: they have a mind of their own","volume":"592","author":"Carlton","year":"2014","journal-title":"J. Physiol."},{"issue":"7","key":"10.1016\/j.expneurol.2022.114108_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071596","article-title":"Ion channels involved in substance P-mediated nociception and Antinociception","volume":"20","author":"Chang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.expneurol.2022.114108_bb0100","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/annrheumdis-2014-205348","article-title":"Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial","volume":"74","author":"Chevalier","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.expneurol.2022.114108_bb0105","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/bja\/ael344","article-title":"Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers","volume":"98","author":"Chizh","year":"2007","journal-title":"Br. J. Anaesth."},{"issue":"4","key":"10.1016\/j.expneurol.2022.114108_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ph9040066","article-title":"Use of capsaicin to treat pain: mechanistic and therapeutic considerations","volume":"9","author":"Chung","year":"2016","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.expneurol.2022.114108_bb0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0304-3940(00)01173-3","article-title":"Intracerebroventricular administration of brain-derived neurotrophic factor in adult rats affects analgesia and spontaneous behaviour but not memory retention in a Morris water maze task","volume":"287","author":"Cirulli","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2022.114108_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107528","article-title":"Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans","volume":"211","author":"de Vries","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.expneurol.2022.114108_bb0125","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.10893","article-title":"Neurophysiologic evidence for a central sensitization in patients with fibromyalgia","volume":"48","author":"Desmeules","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.expneurol.2022.114108_bb0130","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1172\/JCI42843","article-title":"Nociceptors: the sensors of the pain pathway","volume":"120","author":"Dubin","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"9 Suppl","key":"10.1016\/j.expneurol.2022.114108_bb0135","doi-asserted-by":"crossref","first-page":"T70","DOI":"10.1016\/j.jpain.2016.01.001","article-title":"The role of psychosocial processes in the development and maintenance of chronic pain","volume":"17","author":"Edwards","year":"2016","journal-title":"J. Pain"},{"key":"10.1016\/j.expneurol.2022.114108_bb0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2014.11.031","article-title":"Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier","volume":"1600","author":"Eftekhari","year":"2015","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.expneurol.2022.114108_bb0145","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.tics.2018.07.015","article-title":"Memory control: a fundamental mechanism of emotion regulation","volume":"22","author":"Engen","year":"2018","journal-title":"Trends Cogn. Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010069","article-title":"The Glutamatergic system in primary somatosensory neurons and its involvement in sensory input-dependent plasticity","volume":"19","author":"Fernandez-Montoya","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.expneurol.2022.114108_bb0155","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1037\/0033-2909.133.4.581","article-title":"The biopsychosocial approach to chronic pain: scientific advances and future directions","volume":"133","author":"Gatchel","year":"2007","journal-title":"Psychol. Bull."},{"issue":"Suppl. 3","key":"10.1016\/j.expneurol.2022.114108_bb0160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1464-410X.2008.07493.x","article-title":"The concept of neurogenic inflammation","volume":"101","author":"Geppetti","year":"2008","journal-title":"BJU Int."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0006-8993(87)91335-7","article-title":"Two immunohistochemically identified populations of calcitonin gene-related peptide (CGRP)-immunoreactive axons in human skin","volume":"414","author":"Gibbins","year":"1987","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.expneurol.2022.114108_bb0170","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.2235","article-title":"Nociceptor sensitization in pain pathogenesis","volume":"16","author":"Gold","year":"2010","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.expneurol.2022.114108_bb0175","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s13238-017-0395-5","article-title":"TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization","volume":"8","author":"Gouin","year":"2017","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/j.pain.0000000000001694","article-title":"Peripheral brain-derived neurotrophic factor contributes to chronic osteoarthritis joint pain","volume":"161","author":"Gowler","year":"2020","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.expneurol.2022.114108_bb0185","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1089\/neu.2016.4626","article-title":"When pain hurts: nociceptive stimulation induces a state of maladaptive plasticity and impairs recovery after spinal cord injury","volume":"34","author":"Grau","year":"2017","journal-title":"J. Neurotrauma"},{"issue":"3","key":"10.1016\/j.expneurol.2022.114108_bb0190","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0304-3959(99)00308-5","article-title":"Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients","volume":"85","author":"Graven-Nielsen","year":"2000","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.expneurol.2022.114108_bb0195","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.neuron.2019.01.012","article-title":"A mast-cell-specific receptor mediates neurogenic inflammation and pain","volume":"101","author":"Green","year":"2019","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.expneurol.2022.114108_bb0200","first-page":"217","article-title":"The difference between acute and chronic pain","volume":"58","author":"Grichnik","year":"1991","journal-title":"Mt Sinai J. Med."},{"issue":"11","key":"10.1016\/j.expneurol.2022.114108_bb0205","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","article-title":"Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the global burden of disease study 2015","volume":"16","author":"Group, G. B. D. N. D. C","year":"2017","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.expneurol.2022.114108_bb0210","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bja.2019.07.026","article-title":"Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential","volume":"123","author":"Guo","year":"2019","journal-title":"Br. J. Anaesth."},{"issue":"9","key":"10.1016\/j.expneurol.2022.114108_bb0215","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/ejp.1297","article-title":"European pain federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management","volume":"22","author":"Hauser","year":"2018","journal-title":"Eur. J. Pain"},{"issue":"8","key":"10.1016\/j.expneurol.2022.114108_bb0220","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/ejp.1786","article-title":"Is Europe also facing an opioid crisis?-a survey of European pain federation chapters","volume":"25","author":"Hauser","year":"2021","journal-title":"Eur. J. Pain"},{"issue":"2","key":"10.1016\/j.expneurol.2022.114108_bb0225","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tips.2005.12.001","article-title":"Novel class of pain drugs based on antagonism of NGF","volume":"27","author":"Hefti","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.expneurol.2022.114108_bb0230","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0701209","article-title":"Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals","volume":"121","author":"Helyes","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2022.114108_bb0235","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1038\/srep04094","article-title":"GluN2B and GluN2D NMDARs dominate synaptic responses in the adult spinal cord","volume":"4","author":"Hildebrand","year":"2014","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.expneurol.2022.114108_bb0240","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/head.14068","article-title":"Erenumab patient characteristics, medication adherence, and treatment patterns in the United States","volume":"61","author":"Hines","year":"2021","journal-title":"Headache."},{"issue":"5","key":"10.1016\/j.expneurol.2022.114108_bb0245","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.pain.2013.01.002","article-title":"The CGRP receptor antagonist BIBN4096BS peripherally alleviates inflammatory pain in rats","volume":"154","author":"Hirsch","year":"2013","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.expneurol.2022.114108_bb0250","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2010.127","article-title":"CGRP and its receptors provide new insights into migraine pathophysiology","volume":"6","author":"Ho","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.expneurol.2022.114108_bb0255","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/ng0896-485","article-title":"Mutations in the TRKA\/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis","volume":"13","author":"Indo","year":"1996","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.expneurol.2022.114108_bb0260","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/j.pain.0000000000000831","article-title":"The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine","volume":"158","author":"Iyengar","year":"2017","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.expneurol.2022.114108_bb0265","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/head.13529","article-title":"CGRP and the trigeminal system in migraine","volume":"59","author":"Iyengar","year":"2019","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.expneurol.2022.114108_bb0270","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"issue":"11","key":"10.1016\/j.expneurol.2022.114108_bb0275","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41583-019-0218-1","article-title":"Astrocytes in chronic pain and itch","volume":"20","author":"Ji","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2022.114108_bb0280","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pain.2003.09.008","article-title":"NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release","volume":"106","author":"Juhasz","year":"2003","journal-title":"Pain"},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2022.114108_bb0285","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0304-3940(90)90723-M","article-title":"The effects of substance P and calcitonin gene-related peptide on the efflux of endogenous glutamate and aspartate from the rat spinal dorsal horn in vitro","volume":"108","author":"Kangrga","year":"1990","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.expneurol.2022.114108_bb0290","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/head.14053","article-title":"Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: results from the assessment of TolerabiliTy and effectiveness in MigrAINe patients using preventive treatment (ATTAIN) study","volume":"61","author":"Kawata","year":"2021","journal-title":"Headache."},{"key":"10.1016\/j.expneurol.2022.114108_bb0295","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-clinpsy-090310-120430","article-title":"Psychological treatment of chronic pain","volume":"7","author":"Kerns","year":"2011","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"3 Pt 2","key":"10.1016\/j.expneurol.2022.114108_bb0300","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1523\/JNEUROSCI.14-03-01756.1994","article-title":"Differential ability of human cutaneous nociceptors to signal mechanical pain and to produce vasodilatation","volume":"14","author":"Koltzenburg","year":"1994","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.expneurol.2022.114108_bb0305","doi-asserted-by":"crossref","first-page":"eaax9140","DOI":"10.1126\/sciadv.aax9140","article-title":"Current status of opioid addiction treatment and related preclinical research","volume":"5","author":"Kreek","year":"2019","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.expneurol.2022.114108_bb0310","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/nm.2231","article-title":"Central mechanisms of pathological pain","volume":"16","author":"Kuner","year":"2010","journal-title":"Nat. Med."},{"issue":"16","key":"10.1016\/j.expneurol.2022.114108_bb0315","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa0901510","article-title":"Tanezumab for the treatment of pain from osteoarthritis of the knee","volume":"363","author":"Lane","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0320","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","article-title":"CGRP may play a causative role in migraine","volume":"22","author":"Lassen","year":"2002","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.expneurol.2022.114108_bb0325","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: a generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"J. Pain"},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0330","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0006-8993(85)90027-7","article-title":"Coexistence of calcitonin gene-related peptide and substance P-like peptide in single cells of the trigeminal ganglion of the rat: immunohistochemical analysis","volume":"330","author":"Lee","year":"1985","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.expneurol.2022.114108_bb0335","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0166-2236(96)10058-8","article-title":"Nerve growth factor: from neurotrophin to neurokine","volume":"19","author":"Levi-Montalcini","year":"1996","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0340","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s10194-020-01170-x","article-title":"Gut microbiota regulates neuropathic pain: potential mechanisms and therapeutic strategy","volume":"21","author":"Lin","year":"2020","journal-title":"J Headache Pain"},{"issue":"6626","key":"10.1016\/j.expneurol.2022.114108_bb0345","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/386721a0","article-title":"NMDA-receptor regulation of substance P release from primary afferent nociceptors","volume":"386","author":"Liu","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2022.114108_bb0350","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neubiorev.2017.02.026","article-title":"Don\u2019t fear \u2018fear conditioning\u2019: methodological considerations for the design and analysis of studies on human fear acquisition, extinction, and return of fear","volume":"77","author":"Lonsdorf","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.expneurol.2022.114108_bb0355","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1186\/ar4044","article-title":"Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee","volume":"14","author":"Maksymowych","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"Suppl. 11","key":"10.1016\/j.expneurol.2022.114108_bb0360","first-page":"6","article-title":"Neurobiology of substance P and the NK1 receptor","volume":"63","author":"Mantyh","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"19","key":"10.1016\/j.expneurol.2022.114108_bb0365","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1111\/bph.15208","article-title":"Cannabinoid control of neurogenic inflammation","volume":"177","author":"McKenna","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.expneurol.2022.114108_bb0370","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm0895-774","article-title":"The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule","volume":"1","author":"McMahon","year":"1995","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.expneurol.2022.114108_bb0375","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2010.03.002","article-title":"Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain","volume":"149","author":"McNamee","year":"2010","journal-title":"Pain"},{"issue":"Pt B","key":"10.1016\/j.expneurol.2022.114108_bb0380","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pnpbp.2018.01.017","article-title":"Evaluating psychosocial contributions to chronic pain outcomes","volume":"87","author":"Meints","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.expneurol.2022.114108_bb0385","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/ejp.1767","article-title":"Opioids: a \u2018crisis\u2019 of too much or not enough - or simply how rich you are and where you live?","volume":"25","author":"Miyachi","year":"2021","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.expneurol.2022.114108_bb0390","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918807102","article-title":"Predominant synaptic potentiation and activation in the right central amygdala are independent of bilateral parabrachial activation in the hemilateral trigeminal inflammatory pain model of rats","volume":"14","author":"Miyazawa","year":"2018","journal-title":"Mol. Pain"},{"key":"10.1016\/j.expneurol.2022.114108_bb0395","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fnins.2019.00533","article-title":"Nerve growth factor pathobiology during the progression of Alzheimer\u2019s disease","volume":"13","author":"Mufson","year":"2019","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.expneurol.2022.114108_bb0400","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0304-3959(02)00482-7","article-title":"Congenital insensitivity to pain: an update","volume":"101","author":"Nagasako","year":"2003","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.expneurol.2022.114108_bb0405","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuron.2019.01.034","article-title":"Substance P and inflammatory pain: getting it wrong and right simultaneously","volume":"101","author":"Navratilova","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2022.114108_bb0410","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-3-662-46450-2_13","article-title":"Amygdala pain mechanisms","volume":"227","author":"Neugebauer","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0415","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/j.pain.0000000000001390","article-title":"The IASP classification of chronic pain for ICD-11: chronic primary pain","volume":"160","author":"Nicholas","year":"2019","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.expneurol.2022.114108_bb0420","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1517\/14728222.2014.994506","article-title":"Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?","volume":"19","author":"Nijs","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.expneurol.2022.114108_bb0425","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917709201","article-title":"Potentiation of NMDA receptor-mediated synaptic transmission at the parabrachial-central amygdala synapses by CGRP in mice","volume":"13","author":"Okutsu","year":"2017","journal-title":"Mol. Pain"},{"issue":"2","key":"10.1016\/j.expneurol.2022.114108_bb0430","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1113\/expphysiol.2012.069922","article-title":"The glutamatergic system as a target for neuropathic pain relief","volume":"98","author":"Osikowicz","year":"2013","journal-title":"Exp. Physiol."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0440","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/cne.10824","article-title":"Somatosensory organization and behavior in naked mole-rats: II. Peripheral structures, innervation, and selective lack of neuropeptides associated with thermoregulation and pain","volume":"465","author":"Park","year":"2003","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0060013","article-title":"Selective inflammatory pain insensitivity in the African naked mole-rat (Heterocephalus glaber)","volume":"6","author":"Park","year":"2008","journal-title":"PLoS Biol."},{"issue":"2","key":"10.1016\/j.expneurol.2022.114108_bb0450","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0196-9781(91)90022-H","article-title":"Calcitonin gene-related peptide, neurokinin a and substance P: effects on nociception and neurogenic inflammation in human skin and temporal muscle","volume":"12","author":"Pedersen-Bjergaard","year":"1991","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbspin.2018.03.004","article-title":"Cannabis for musculoskeletal pain and arthritis: evidence is needed","volume":"86","author":"Perrot","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.expneurol.2022.114108_bb0460","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.neuro.29.051605.112929","article-title":"Neurotrophins: mediators and modulators of pain","volume":"29","author":"Pezet","year":"2006","journal-title":"Annu. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0465","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2016.10.001","article-title":"Nociceptor sensory neuron-immune interactions in pain and inflammation","volume":"38","author":"Pinho-Ribeiro","year":"2017","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.expneurol.2022.114108_bb0470","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0304-3959(94)90069-8","article-title":"The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man","volume":"59","author":"Price","year":"1994","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0475","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpain.2014.10.001","article-title":"Spatial summation of pain in humans investigated using transcutaneous electrical stimulation","volume":"16","author":"Reid","year":"2015","journal-title":"J. Pain"},{"issue":"5","key":"10.1016\/j.expneurol.2022.114108_bb0480","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/ACO.0b013e32830edbdf","article-title":"Neuron-glia crosstalk gets serious: role in pain hypersensitivity","volume":"21","author":"Ren","year":"2008","journal-title":"Curr. Opin. Anaesthesiol."},{"issue":"4","key":"10.1016\/j.expneurol.2022.114108_bb0485","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.pain.2010.12.041","article-title":"Pain catastrophizing is related to temporal summation of pain but not temporal summation of the nociceptive flexion reflex","volume":"152","author":"Rhudy","year":"2011","journal-title":"Pain"},{"issue":"Suppl 1","key":"10.1016\/j.expneurol.2022.114108_bb0490","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/j.pain.0000000000002210","article-title":"Presenting the outputs of the IASP presidential task force on Cannabis and cannabinoid analgesia","volume":"162","author":"Rice","year":"2021","journal-title":"Pain."},{"issue":"4","key":"10.1016\/j.expneurol.2022.114108_bb0495","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.expneurol.2022.114108_bb0500","first-page":"318","article-title":"Cellular neuroplasticity mechanisms mediating pain persistence","volume":"18","author":"Salter","year":"2004","journal-title":"J. Orofac. Pain"},{"issue":"6","key":"10.1016\/j.expneurol.2022.114108_bb0505","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.autrev.2018.12.009","article-title":"Systemic rheumatic diseases: from biological agents to small molecules","volume":"18","author":"Sarzi-Puttini","year":"2019","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.expneurol.2022.114108_bb0510","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archsurg.133.10.1107","article-title":"Neuropeptides: mediators of inflammation and tissue repair?","volume":"133","author":"Schaffer","year":"1998","journal-title":"Arch. Surg."},{"issue":"2","key":"10.1016\/j.expneurol.2022.114108_bb0515","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/ar3305","article-title":"Update on peripheral mechanisms of pain: beyond prostaglandins and cytokines","volume":"13","author":"Schaible","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0520","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13075-017-1410-1","article-title":"Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment","volume":"19","author":"Schiff","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"23","key":"10.1016\/j.expneurol.2022.114108_bb0525","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.2017.5787","article-title":"Primary Care of Patients with Chronic Pain","volume":"317","author":"Schneiderhan","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.expneurol.2022.114108_bb0530","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-204905","article-title":"Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain","volume":"74","author":"Schnitzer","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.expneurol.2022.114108_bb0535","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1533-2500.2010.00358.x","article-title":"Transient receptor potential channels in pain and inflammation: therapeutic opportunities","volume":"10","author":"Schumacher","year":"2010","journal-title":"Pain Pract"},{"issue":"2\u20133","key":"10.1016\/j.expneurol.2022.114108_bb0540","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s12026-014-8565-5","article-title":"New treatments for inflammatory rheumatic disease","volume":"60","author":"Selmi","year":"2014","journal-title":"Immunol. Res."},{"issue":"47","key":"10.1016\/j.expneurol.2022.114108_bb0545","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.1523\/JNEUROSCI.1049-18.2018","article-title":"Insensitivity to pain upon adult-onset deletion of Nav1.7 or its blockade with selective inhibitors","volume":"38","author":"Shields","year":"2018","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2022.114108_bb0550","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/ejn.13662","article-title":"Essential role of endogenous calcitonin gene-related peptide in pain-associated plasticity in the central amygdala","volume":"46","author":"Shinohara","year":"2017","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2022.114108_bb0555","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0196-9781(84)90177-3","article-title":"A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system","volume":"5","author":"Shults","year":"1984","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.expneurol.2022.114108_bb0560","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/eujp.2000.0171","article-title":"Substance P","volume":"4","author":"Snijdelaar","year":"2000","journal-title":"Eur. J. Pain"},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2022.114108_bb0565","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/s0304-3959(02)00344-5","article-title":"Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome","volume":"102","author":"Staud","year":"2003","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.expneurol.2022.114108_bb0570","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/art.40894","article-title":"Randomized, double-blind, placebo-controlled trial of Intraarticular trans-capsaicin for pain associated with osteoarthritis of the knee","volume":"71","author":"Stevens","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.expneurol.2022.114108_bb0575","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1002\/art.38778","article-title":"Structural associations of symptomatic knee osteoarthritis","volume":"66","author":"Stoppiello","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.expneurol.2022.114108_bb0580","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJMoa1608345","article-title":"Baricitinib versus placebo or Adalimumab in rheumatoid arthritis","volume":"376","author":"Taylor","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4 Suppl","key":"10.1016\/j.expneurol.2022.114108_bb0585","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/00002508-200112001-00003","article-title":"Pathophysiology of chronic pain disorders","volume":"17","author":"Teasell","year":"2001","journal-title":"Clin. J. Pain"},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2022.114108_bb0590","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neulet.2006.01.018","article-title":"Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat","volume":"399","author":"Ultenius","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2022.114108_bb0595","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.3389\/fimmu.2019.03009","article-title":"Cytokines in pain: harnessing endogenous anti-inflammatory signaling for improved pain management","volume":"10","author":"Vanderwall","year":"2019","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2022.114108_bb0600","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pain.2007.12.008","article-title":"Clinical and pre-clinical pain assessment: are we measuring the same thing?","volume":"135","author":"Vierck","year":"2008","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.expneurol.2022.114108_bb0605","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1152\/jn.1997.78.2.992","article-title":"Characteristics of temporal summation of second pain sensations elicited by brief contact of glabrous skin by a preheated thermode","volume":"78","author":"Vierck","year":"1997","journal-title":"J. Neurophysiol."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0610","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/1673-5374.243719","article-title":"Effects of TRPA1 activation and inhibition on TRPA1 and CGRP expression in dorsal root ganglion neurons","volume":"14","author":"Wang","year":"2019","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.expneurol.2022.114108_bb0615","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0072-9752(06)80013-8","article-title":"Chapter 9 the dorsal horn and hyperalgesia","volume":"81","author":"Westlund","year":"2006","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0620","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41584-020-00528-4","article-title":"The evolution of nerve growth factor inhibition in clinical medicine","volume":"17","author":"Wise","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9","key":"10.1016\/j.expneurol.2022.114108_bb0625","first-page":"646","article-title":"Burden of major musculoskeletal conditions","volume":"81","author":"Woolf","year":"2003","journal-title":"Bull. World Health Organ."},{"issue":"5472","key":"10.1016\/j.expneurol.2022.114108_bb0630","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1126\/science.288.5472.1765","article-title":"Neuronal plasticity: increasing the gain in pain","volume":"288","author":"Woolf","year":"2000","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.expneurol.2022.114108_bb0635","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0304-3959(91)90100-C","article-title":"The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states","volume":"44","author":"Woolf","year":"1991","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.expneurol.2022.114108_bb0640","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/ACO.0b013e32834871df","article-title":"A brief comparison of the pathophysiology of inflammatory versus neuropathic pain","volume":"24","author":"Xu","year":"2011","journal-title":"Curr. Opin. Anaesthesiol."},{"issue":"3","key":"10.1016\/j.expneurol.2022.114108_bb0645","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1471-4159.2005.03045.x","article-title":"Direct evidence for the involvement of brain-derived neurotrophic factor in the development of a neuropathic pain-like state in mice","volume":"93","author":"Yajima","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2022.114108_bb0650","doi-asserted-by":"crossref","first-page":"56","DOI":"10.12703\/P7-56","article-title":"The search for novel analgesics: targets and mechanisms","volume":"7","author":"Yaksh","year":"2015","journal-title":"F1000Prime Rep"},{"issue":"8","key":"10.1016\/j.expneurol.2022.114108_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082164","article-title":"General pathways of pain sensation and the major neurotransmitters involved in pain regulation","volume":"19","author":"Yam","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.expneurol.2022.114108_bb0660","first-page":"938","article-title":"Therapeutic effects and safety of olcegepant and telcagepant for migraine: a meta-analysis","volume":"8","author":"Yao","year":"2013","journal-title":"Neural Regen. Res."},{"issue":"6","key":"10.1016\/j.expneurol.2022.114108_bb0665","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jpain.2017.12.261","article-title":"Inflammatory and neuropathic pain from bench to bedside: what went wrong?","volume":"19","author":"Yezierski","year":"2018","journal-title":"J. Pain"},{"issue":"3","key":"10.1016\/j.expneurol.2022.114108_bb0670","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.berh.2007.03.006","article-title":"Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain","volume":"21","author":"Yunus","year":"2007","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.expneurol.2022.114108_bb0675","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2004.05.042","article-title":"NGF-mediated sensitization of the excitability of rat sensory neurons is prevented by a blocking antibody to the p75 neurotrophin receptor","volume":"366","author":"Zhang","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0680","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1460-9568.2000.00884.x","article-title":"Neurotrophins from dorsal root ganglia trigger allodynia after spinal nerve injury in rats","volume":"12","author":"Zhou","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.expneurol.2022.114108_bb0685","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/head.13729","article-title":"Non-responders to treatment with antibodies to the CGRP-receptor May profit from a switch of antibody class","volume":"60","author":"Ziegeler","year":"2020","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.expneurol.2022.114108_bb0690","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00441-018-2922-y","article-title":"Substance P and pain chronicity","volume":"375","author":"Zieglgansberger","year":"2019","journal-title":"Cell Tissue Res."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488622001339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488622001339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:10:34Z","timestamp":1758003034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488622001339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":138,"alternative-id":["S0014488622001339"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2022.114108","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurogenic inflammation as a novel treatment target for chronic pain syndromes","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2022.114108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114108"}}